Researchers Find Indego® Robotic Exoskeleton is Safe and Effective for Assisting Standing and Walking in Some People with Paralysis
The research findings have been included in the Indego FDA submission for approval of the device for clinical and personal use.
A five-site clinical trial of a robotic exoskeleton shows the device is safe and effective in assisting standing and walking in persons with paraplegia on both indoor and outdoor surfaces.
Shepherd Center, which has been leading the Indego® research since 2010, and four other research partners collected data on 40 study participants with paraplegia who tested the device. Indego is being developed and manufactured by Ohio-based Parker Hannifin Corp. Additional rehabilitation sites who participated in the 40-subject study completed in July 2015 were Craig Hospital (Colorado), Kessler Rehabilitation Institute (New Jersey), Rehabilitation Institute of Chicago (Illinois) and Rusk Rehabilitation Institute (New York).
Parker submitted the data in August 2015 to the U.S. Food and Drug Administration, requesting approval of the device for personal and clinical use. The submission is under review, and the company expects clearance in the next few months.
“Our Shepherd Center research team is very proud to be working with Indego,” said research project manager Clare Hartigan, PT, MPT. “The options Indego offers our patients in terms of rehabilitation, mobility and personal use are unprecedented.”
While other exoskeletons are being used in rehabilitation settings, there are several features about the Indego device that set it apart, Hartigan notes.
- At 26 pounds, it is about half the weight of other exoskeleton devices.
- Indego can be disassembled into five pieces for easier portability.
- Users find the Indego operation is straightforward and logical.
- Indego was developed specifically to be appropriate for personal use as a means of both standing and walking in home and community settings.
Shepherd Center’s research with Indego will continue with individuals with tetraplegia (also called quadriplegia), stroke and multiple sclerosis. To complete a research intake form to be considered for Indego studies, visit shepherd.org/research and click on the Indego Clinical Trials icon.
For more information on Indego, visit indego.com.
Shepherd Center, located in Atlanta, Georgia, is a private, not-for-profit hospital specializing in medical treatment, research and rehabilitation for people with spinal cord injury, brain injury, multiple sclerosis, spine and chronic pain, and other neuromuscular conditions. Founded in 1975, Shepherd Center is ranked by U.S. News & World Report among the top 10 rehabilitation hospitals in the nation. In its more than four decades, Shepherd Center has grown from a six-bed rehabilitation unit to a world-renowned, 152-bed hospital that treats more than 743 inpatients, 277 day program patients and more than 7,161 outpatients each year in more than 46,000 visits.